Innova Captab Limited
NSE: INNOVACAP
NSE
723.15
32.50 (4.71%)
Prev Close
690.65001
Open Price
724.95
Volume
38,298
Today Low / High
696.6 / 733.95
52 WK Low / High
624 / 1024
Range
687 - 759
Currently, the stock is trading on the National Stock Exchange (NSE). The stock price stands at 723.15, with a change of 32.49999 (4.70571%). The expected target range on the NSE is between 687 - 759. The stock is trending upwards on the NSE, which could present a good opportunity for potential investors.
03 Feb
724.95
-0.25%
02 Feb
694.90
-0.61%
01 Feb
685.00
1.30%
30 Jan
676.10
2.83%
29 Jan
700.00
-3.24%
28 Jan
701.10
-0.66%
27 Jan
678.95
3.24%
23 Jan
654.20
3.65%
22 Jan
649.20
0.77%
21 Jan
645.00
0.65%
20 Jan
632.65
3.18%
19 Jan
665.35
-3.10%
16 Jan
680.05
-0.86%
14 Jan
684.00
-0.70%
13 Jan
693.00
-0.71%
12 Jan
703.00
-2.60%
09 Jan
732.10
-3.88%
08 Jan
728.95
0.14%
07 Jan
732.25
-0.06%
06 Jan
734.85
-0.53%
Innova Captab Limited Graph
Innova Captab Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Innova Captab Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 723.15, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 723.15 | 730.38 | 657.34 - 803.42 |
| 737.61 | 590.09 - 885.14 | ||
| 744.84 | 521.39 - 968.30 | ||
| Bearish Scenario | 723.15 | 715.92 | 644.33 - 787.51 |
| 708.69 | 566.95 - 850.42 | ||
| 701.46 | 491.02 - 911.89 |
Overview of Innova Captab Limited
ISIN
INE0DUT01020
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
93,605
Market Cap
41,327,843,724
Last Dividend
4
Official Website
IPO Date
2023-12-29
DCF Diff
1,175.67
DCF
-442
Financial Ratios Every Investor Needs
Stock Dividend of INNOVACAP
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2026-01-30 | January 30, 26 | 2 | 2 | 2026-01-30 | 2026-02-22 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1,243.68 Cr | 814.10 Cr | 429.58 Cr | 0.3454 | 6.55 Cr | 120.80 Cr | 312.80 Cr | 128.26 Cr | 22.41 | 186.16 Cr | 0.1031 |
| 2024-03-31 | 1,076.96 Cr | 734.86 Cr | 342.10 Cr | 0.3177 | 5.70 Cr | 91.57 Cr | 138.59 Cr | 94.35 Cr | 18.66 | 166.83 Cr | 0.0876 |
| 2023-03-31 | 926.38 Cr | 691.56 Cr | 234.82 Cr | 0.2535 | 0.00 Cr | 55.35 Cr | 103.31 Cr | 67.95 Cr | 14.16 | 122.83 Cr | 0.0734 |
| 2022-03-31 | 799.77 Cr | 626.40 Cr | 173.38 Cr | 0.2168 | 0.00 Cr | 1.65 Cr | 88.69 Cr | 63.95 Cr | 11.18 | 98.77 Cr | 0.0800 |
| 2021-03-31 | 409.56 Cr | 314.31 Cr | 61.14 Cr | 0.1493 | 0.00 Cr | 1.22 Cr | 48.15 Cr | 34.50 Cr | 287.50 | 55.86 Cr | 0.0842 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 15.52 Cr | 1,580.41 Cr | 620.99 Cr | 959.4170 Cr | 338.12 Cr | 269.95 Cr | 208.00 Cr | 834.95 Cr | 0.00 Cr | 0.00 Cr | 6.42 Cr | 353.0040 Cr |
| 2024-03-31 | 11.73 Cr | 1,320.88 Cr | 489.99 Cr | 830.8940 Cr | 245.10 Cr | 233.38 Cr | 144.02 Cr | 681.08 Cr | 13.10 Cr | 0.00 Cr | -69.80 Cr | 265.4810 Cr |
| 2023-03-31 | 13.29 Cr | 1,018.72 Cr | 693.13 Cr | 276.5060 Cr | 236.97 Cr | 419.48 Cr | 117.32 Cr | 357.88 Cr | 50.85 Cr | 0.09 Cr | -48.03 Cr | 277.5500 Cr |
| 2022-03-31 | 0.15 Cr | 575.48 Cr | 366.87 Cr | 208.6060 Cr | 199.17 Cr | 199.02 Cr | 128.39 Cr | 165.92 Cr | 3.59 Cr | 0.09 Cr | -0.69 Cr | 294.5190 Cr |
| 2021-03-31 | 4.80 Cr | 369.62 Cr | 224.80 Cr | 144.8210 Cr | 45.50 Cr | 40.70 Cr | 91.45 Cr | 85.96 Cr | 56.88 Cr | 0.00 Cr | 3.50 Cr | 215.1530 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 63.8440 Cr | -151.5860 Cr | 91.5330 Cr | -108.6510 Cr | 3.7910 Cr | 15.5190 Cr | -172.4950 Cr | 128.2580 Cr | 94.1020 Cr | 0.0000 Cr | -64.0420 Cr |
| 2024-03-31 | 146.3400 Cr | -498.9710 Cr | 360.8340 Cr | -141.0130 Cr | 8.2030 Cr | 11.7280 Cr | -287.3530 Cr | 129.5290 Cr | 53.6080 Cr | 0.0000 Cr | 1.5400 Cr |
| 2023-03-31 | 67.1240 Cr | -90.8430 Cr | 27.0920 Cr | -11.8670 Cr | 3.3730 Cr | 3.5250 Cr | -78.9910 Cr | 67.9540 Cr | -9.8320 Cr | 0.0000 Cr | 10.8420 Cr |
| 2022-03-31 | 58.8980 Cr | -188.1150 Cr | 124.5740 Cr | -20.9850 Cr | -4.6430 Cr | 0.1520 Cr | -79.8830 Cr | 63.9530 Cr | 130.8850 Cr | 0.0000 Cr | -11.4310 Cr |
| 2021-03-31 | 38.1600 Cr | -19.6680 Cr | -19.3360 Cr | 22.8330 Cr | 2.5620 Cr | 4.7950 Cr | -18.7330 Cr | 34.5000 Cr | -15.7070 Cr | 0.0000 Cr | -4.4100 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 450.29 Cr | 347.03 Cr | 103.27 Cr | 0.2293 | 57.97 Cr | 42.15 Cr | 7.37 | 71.05 Cr | 0.0936 |
| 2025-09-30 | 380.38 Cr | 296.62 Cr | 83.76 Cr | 0.2202 | 40.54 Cr | 29.67 Cr | 5.18 | 56.05 Cr | 0.0780 |
| 2025-06-30 | 351.54 Cr | 220.74 Cr | 130.80 Cr | 0.3721 | 41.05 Cr | 31.02 Cr | 5.42 | 56.58 Cr | 0.0882 |
| 2025-03-31 | 314.74 Cr | 198.02 Cr | 116.72 Cr | 0.3708 | 81.20 Cr | 29.57 Cr | 5.17 | 44.08 Cr | 0.0940 |
| 2024-12-31 | 316.46 Cr | 209.93 Cr | 106.53 Cr | 0.3366 | 41.43 Cr | 34.20 Cr | 5.97 | 50.89 Cr | 0.1081 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 58.44 Cr | 0.00 Cr | 58.44 Cr | 395.74 Cr | 235.85 Cr | 812.03 Cr | 836.92 Cr | 1,692.14 Cr | 671.00 Cr |
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 65.28 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -959.42 Cr |
| 2025-03-31 | 15.52 Cr | 49.76 Cr | 65.28 Cr | 331.65 Cr | 208.00 Cr | 703.11 Cr | 834.95 Cr | 1,580.41 Cr | 620.99 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 18.14 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -895.30 Cr |
| 2024-09-30 | 3.38 Cr | 14.76 Cr | 18.14 Cr | 330.14 Cr | 175.19 Cr | 585.06 Cr | 795.80 Cr | 1,434.55 Cr | 539.25 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 31.02 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | 29.57 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 34.20 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 35.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 29.48 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,697.80 | ₹4,073,590,912,066.00 | ₹3,930,868.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,290.00 | ₹1,669,797,368,200.00 | ₹244,814.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹4,033.60 | ₹1,365,153,526,784.00 | ₹240,277.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,231.80 | ₹1,025,557,496,442.00 | ₹761,638.00 |
| Lupin Limited | LUPIN | ₹2,190.80 | ₹1,000,755,249,200.00 | ₹367,005.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹906.80 | ₹912,452,982,132.00 | ₹347,388.00 |
| Mankind Pharma Limited | MANKIND | ₹2,159.30 | ₹891,369,991,970.00 | ₹116,092.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,236.30 | ₹718,045,046,515.00 | ₹1,217,552.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,698.00 | ₹681,281,370,000.00 | ₹69,308.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹1,979.40 | ₹558,588,281,335.00 | ₹233,253.00 |
| Laurus Labs Limited | LAURUSLABS | ₹980.35 | ₹529,248,400,164.00 | ₹951,956.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,443.40 | ₹366,196,668,261.00 | ₹54,740.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,837.00 | ₹354,442,365,288.00 | ₹25,237.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,894.10 | ₹303,879,933,500.00 | ₹86,928.00 |
| Emcure Pharmaceuticals Ltd. | EMCURE | ₹1,503.70 | ₹285,060,228,398.00 | ₹62,288.00 |
| Piramal Enterprises Limited | PEL | ₹1,124.20 | ₹254,856,250,172.00 | ₹2,148,582.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,349.00 | ₹219,201,935,981.00 | ₹408,785.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹8,649.50 | ₹216,237,500,000.00 | ₹2,110.00 |
| Eris Lifesciences Limited | ERIS | ₹1,428.20 | ₹194,544,963,726.00 | ₹13,251.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹13,435.00 | ₹172,369,558,715.00 | ₹18,003.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹988.90 | ₹156,611,843,797.00 | ₹50,041.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹793.40 | ₹155,953,182,582.00 | ₹14,005.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹853.00 | ₹152,780,719,110.00 | ₹355,318.00 |
| Cohance Lifesciences Limited | COHANCE | ₹386.60 | ₹147,900,456,324.00 | ₹145,589.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹1,836.00 | ₹139,557,473,856.00 | ₹30,496.00 |
| Granules India Limited | GRANULES | ₹569.30 | ₹138,151,300,019.00 | ₹257,455.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Alivus Life Sciences Ltd. | ALIVUS | ₹955.05 | ₹117,219,016,800.00 | ₹36,675.00 |
| Viyash Scientific Limited | VIYASH | ₹216.91 | ₹94,617,347,803.00 | ₹984,027.00 |
| Procter & Gamble Health Limited | PGHL | ₹5,288.50 | ₹87,785,831,707.00 | ₹10,667.00 |
| Strides Pharma Science Limited | STAR | ₹863.10 | ₹79,554,269,453.00 | ₹148,496.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹789.55 | ₹71,570,570,978.00 | ₹68,670.00 |
| Akums Drugs & Pharmaceuticals Ltd. | AKUMS | ₹452.50 | ₹69,278,681,245.00 | ₹71,811.00 |
| FDC Limited | FDC | ₹381.20 | ₹62,063,204,021.00 | ₹23,733.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹299.85 | ₹58,645,207,528.00 | ₹235,068.00 |
| Sequent Scientific Limited | SEQUENT | ₹202.40 | ₹50,564,340,966.00 | ₹13,647.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹144.94 | ₹47,036,158,965.00 | ₹2,957,569.00 |
| Innova Captab Limited | INNOVACAP | ₹723.15 | ₹41,382,207,406.00 | ₹38,298.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹399.00 | ₹36,416,730,000.00 | ₹111,236.00 |
| Gujarat Themis Biosyn Ltd. | GUJTHEM | ₹326.40 | ₹35,566,262,496.00 | ₹17,410.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹685.00 | ₹34,742,586,925.00 | ₹32,360.00 |
| Suven Life Sciences Limited | SUVEN | ₹146.50 | ₹33,324,941,000.00 | ₹213,933.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹1,995.00 | ₹32,995,334,925.00 | ₹5,638.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹306.35 | ₹30,721,545,713.00 | ₹21,387.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹397.75 | ₹28,003,887,063.00 | ₹27,679.00 |
Key Executives
Head of Investor Relations
Ayush Kumar Garg
Gender: male
Year Born:
Whole-time Director
Jayant Vasudeo Rao
Gender: male
Year Born: 1964
Chief Financial Officer
Lokesh Bhasin
Gender: male
Year Born:
Executive Chairman
Manoj Kumar Lohariwala
Gender: male
Year Born: 1972
Deputy Chief Financial Officer
MukeshKumar Siyaram Singh
Gender: male
Year Born:
MD & Director
Vinay Kumar Lohariwala
Gender: male
Year Born: 1976
Company Secretary & Compliance Officer
Neeharika Shukla
Gender: female
Year Born:
Company Secretary of Sharon Bio - Medicine Limited
Rakhi Makhloga
Gender: female
Year Born:
FAQs about Innova Captab Limited
Who is the CEO of the company?
The CEO is Manoj Kumar Lohariwala.
What is the current market price of the stock?
The current price is ₹722.20.
What is the 52-week price range?
The range is ₹624-1024.
What is the market capitalization of the company?
The market capitalization is ₹4,132.78 crores.
What is the dividend yield?
The dividend yield is 0.28%.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 31.21.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Innova Captab Limited (ISIN: INE0DUT01020) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹4,132.78 crores and an average daily volume of 93,605 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹4.